Bone Biologics (BBLG) registers 6.5M warrant shares for resale, 357% of current 1.8M outstanding

Filed July 24, 2026 · ~2 min read

Key Changes

• high

  This is a resale registration by selling stockholders, primarily Armistice Capital. The company receives no proceeds from share sales, though it would receive approximately $6.2M in gross proceeds if all warrants are exercised for cash.

  Management's Discussion and Analysis verify on EDGAR →
• high

  The 6.5M registered shares represent 357% of the current 1.8M shares outstanding. If all warrants are exercised, the share count would increase to 8.3M shares, diluting existing holders by more than 3.5x.

  Risk Factors verify on EDGAR →
• high

  Most warrants are out of the money: Series F, Series G, and placement agent warrants carry exercise prices of $1.42, $1.42, and $1.775 versus a $1.24 closing price on July 15, 2026. Only pre-funded warrants ($0.001 strike) are in the money.

  Risk Factors verify on EDGAR →